Evolva Holding AG (SIX: EVE) has announced the acquisition of Allylix, Inc., a yeast fermentation company with a focus on high-value ingredients, based in San Diego, USA, through a share for share exchange transaction with a deal value of approx. CHF 60 mio. The new Evolva shares are expected to be admitted to trading on the SIX Swiss Exchange by mid-December 2014.

Walder Wyss AG advises Allylix, Inc. in this transaction. The team comprises of Alexander Nikitine (Managing Associate, Capital Markets, Corporate/M&A), Lukas Wyss (Partner, Banking Finance) and Alexandre Both (Associate, Corporate/M&A, Banking Finance).